1. Interventional hepatic ApoC-III knockdown improves atherosclerotic plaque stability and remodeling via lowering remnant lipoproteins. (August 2021) Authors: Gordts, P.; Ramms, B.; Pessentheiner, A.; Sun, X.; Ducasa, G.M.; Tsimikas, S.; Witztum, J.L. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The human milk oligosaccharide 3'sialyllactose promotes inflammation resolution and reduces atherosclerosis development. (August 2021) Authors: Pessentheiner, A.; Spann, N.; Collins, C.; Ramms, B.; Chiang, A.; Wang, Y.; Quach, A.; Booshehri, L.; Hammond, A.; Tognaccini, C.; Latasiewicz, J.; Witztum, J.L.; Hoffman, H.; Lewis, N.; Glass, C.; Bode, L.; Gordts, P. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗